Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

In This Issue

In This Issue 14 with other paraneoplastic conditions, in which 75.3% had surgery and 17.3% had radiotherapy and/ • Long-Term Results After or chemotherapy. The study found no significant Treatment for Recurrent difference in disease-free survival between the groups Thymoma: A Multicenter Analysis with and without adjuvant therapy (chemotherapy, 64.0 ± 41.3 months versus 91.5 ± 76.4 months, respectively; radiotherapy, 93.0 ± 62.3 months versus 86.2 ± 72.8 months, respectively). There were 59 cases of local recurrences and 15 hematogenous distant recurrences. Twenty-five of 61 cases had been assigned with more aggressive WHO class at recurrence relative to that at initial thymectomy, without changing the prognosis of patients. The 5-year and 10-year survival rates were 94.8% and 71.7%, respectively, after initial thymectomy, and 82.4% and 65.4%, respectively, after In a study to determine the long-term (5 years and 10 years) treatment for recurrence (when a R0-re-resection was outcomes in patients with recurrent thymoma after radical included). The results also showed an association of thymectomy, Sandri et al. conducted a retrospective analysis a higher risk of re-relapse with the recurrence site of 81 such patients on their clinicopathological characteristics (hematogenous diffusion, p = 0.01). To conclude, thymoma could relapse, mostly local, years after http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

In This Issue

Journal of Thoracic Oncology , Volume 9 (12) – Dec 1, 2014
Download PDF
4 pages

Loading next page...
 
/lp/wolters-kluwer-health/in-this-issue-66zjZOB0qJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2014 by the International Association for the Study of Lung Cancer
ISSN
1556-0864

Abstract

14 with other paraneoplastic conditions, in which 75.3% had surgery and 17.3% had radiotherapy and/ • Long-Term Results After or chemotherapy. The study found no significant Treatment for Recurrent difference in disease-free survival between the groups Thymoma: A Multicenter Analysis with and without adjuvant therapy (chemotherapy, 64.0 ± 41.3 months versus 91.5 ± 76.4 months, respectively; radiotherapy, 93.0 ± 62.3 months versus 86.2 ± 72.8 months, respectively). There were 59 cases of local recurrences and 15 hematogenous distant recurrences. Twenty-five of 61 cases had been assigned with more aggressive WHO class at recurrence relative to that at initial thymectomy, without changing the prognosis of patients. The 5-year and 10-year survival rates were 94.8% and 71.7%, respectively, after initial thymectomy, and 82.4% and 65.4%, respectively, after In a study to determine the long-term (5 years and 10 years) treatment for recurrence (when a R0-re-resection was outcomes in patients with recurrent thymoma after radical included). The results also showed an association of thymectomy, Sandri et al. conducted a retrospective analysis a higher risk of re-relapse with the recurrence site of 81 such patients on their clinicopathological characteristics (hematogenous diffusion, p = 0.01). To conclude, thymoma could relapse, mostly local, years after

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Dec 1, 2014

There are no references for this article.